Mark A Berman; Nicole L Guthrie; Katherine L Edwards; Kevin J Appelbaum; Valentine Njike; David M. Eisenberg; David L. Katz · 2018 · JMIR Diabetes
Paper
BACKGROUND: Intensive lifestyle change can treat and even reverse type 2 diabetes. Digital therapeutics have the potential to deliver lifestyle as medicine for diabetes at scale. OBJECTIVE: ) and diabetes medication use. METHODS: at the beginning and end of the 12-week program. Self-efficacy related to managing diabetes and maintaining dietary changes was assessed via survey. Engagement was recorded automatically through the app. RESULTS: among participants in the highest tertile of app engagement compared to those in the lowest tertile of app engagement (P=.03). CONCLUSIONS: were observed with use of the FareWell digital therapeutic. Greater glycemic control was observed with increasing app engagement. Engagement and retention were both high in this widely distributed sample.
Analysis
Preparing paper insights from the available abstract and paper details.
Discovery
Harsh Sah; Mahima Ramesh; C. Amrutha
Emanuele Arcà; Dorothea Heldt; Martina Smith
Linea Schmidt; Marc Pawlitzki; Bernhard Y. Renard; Sven G. Meuth; Lars Masanneck
Åsa Ingvar; Ibukun Oloruntoba; Maithili Sashindranath; Robert E. Miller; H. Peter Soyer; Pascale Guitera; Tony Caccetta; Stephen Shumack; Lisa M. Abbott; Chris Arnold; Craig Lawn; Alison Button‐Sloan; Monika Janda; Victoria Mar
Rebecca Brotherdale; Katherine Berry; Sandra Bucci
Akihiro Nomura
Source record